Recent challenges in cardiology include the rapid integration of digital health technologies, which, while offering opportunities for remote monitoring and personalized care, also present challenges related to data security, interoperability, and the ethical use of patient information. The emergence of novel cardiovascular therapeutics, including gene and cell-based therapies, brings new possibilities for treatment but poses challenges in terms of regulatory frameworks, long-term safety assessments, and equitable access. Another challenge is the impact of environmental factors on cardiovascular health, with air pollution, climate change, and urbanization influencing the prevalence and severity of cardiovascular diseases. The dynamic nature of infectious diseases, as exemplified by the COVID-19 pandemic, also presents challenges in understanding the long-term cardiovascular consequences of viral infections. Navigating these challenges requires ongoing collaboration among clinicians, researchers, policymakers, and technology developers to develop comprehensive and adaptable strategies for addressing the multifaceted aspects of cardiovascular health in an ever-changing global context.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain